Conversely, hemin directly represses ALAS1 activity, but its long-term exposure has been associated with hepatic iron accumulation, oxidative stress, inflammation, and liver fibrosis in AIP patients alongside refractoriness to the attacks [13,32], growing the need of novel medications. This evidence concerns the gene ALAS1 and Hepatic fibrosis.